Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel | Plasma cell-free+WBC DNA | Molecular Pathology Panels

Roll up to these when you need a wider cohort.

• 1Molecular Pathology PanelsLOINCLP62072-1
• 2Molecular pathologyLOINCLP7822-2
• 3LaboratoryLOINCLP29693-6
• 4{component}LOINCLP432695-7

Included automatically when you query with descendants.

• 1Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNALOINC96978-2
• 2Age at deliveryLOINC43993-5
• 2Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNALOINC75605-6
• 2Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75606-4
• 2Citation [Bibliographic Citation] in Referral lab test NarrativeLOINC75608-0
• 2Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75579-3
• 2Comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75571-0
• 2Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75573-6
• 2Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75553-8
• 2Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75559-5
• 2Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75565-2
• 2Fetal 22q11.2 deletion prior risk [Likelihood] based on general population riskLOINC75574-4
• 2Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk NarrativeLOINC75575-1
• 2Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeLOINC75578-5
• 2Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNALOINC75576-9
• 2Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75577-7
• 2Fetal Monosomy X prior risk [Likelihood] Based on maternal ageLOINC75566-0
• 2Fetal Monosomy X prior risk [Likelihood] Based on maternal age NarrativeLOINC75568-6
• 2Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeLOINC75570-2
• 2Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNALOINC75567-8
• 2Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeLOINC75569-4
• 2Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNALOINC75604-9
• 2Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeLOINC75572-8
• 2Fetal Trisomy 13 prior risk [Likelihood] Based on maternal ageLOINC75546-2
• 2Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age NarrativeLOINC75550-4

Showing 25 of 48. Retrieve the full set via the API.